Literature DB >> 22125050

Investigation of the impact of Tat export pathway enhancement on E. coli culture, protein production and early stage recovery.

Steven D Branston1, Cristina F R O Matos, Robert B Freedman, Colin Robinson, Eli Keshavarz-Moore.   

Abstract

The twin arginine translocation (Tat) pathway occurs naturally in E. coli and has the distinct ability to translocate folded proteins across the inner membrane of the cell. It has the potential to export commercially useful proteins that cannot be exported by the ubiquitous Sec pathway. To better understand the bioprocess potential of the Tat pathway, this article addresses the fermentation and downstream processing performances of E. coli strains with a wild-type Tat system exporting the over-expressed substrate protein FhuD. These were compared to strains cell-engineered to over-express the Tat pathway, since the native export capacity of the Tat pathway is low. This low capacity makes the pathway susceptible to saturation by over-expressed substrate proteins, and can result in compromised cell integrity. However, there is concern in the literature that over-expression of membrane proteins, like those of the Tat pathway, can impact negatively upon membrane integrity itself. Under controlled fermentation conditions E. coli cells with a wild-type Tat pathway showed poor protein accumulation, reaching a periplasmic maximum of only 0.5 mg L⁻¹ of growth medium. Cells over-expressing the Tat pathway showed a 25% improvement in growth rate, avoided pathway saturation, and showed 40-fold higher periplasmic accumulation of FhuD. Moreover, this was achieved whilst conserving the integrity of cells for downstream processing: experimentation comparing the robustness of cells to increasing levels of shear showed no detrimental effect from pathway over-expression. Further experimentation on spheroplasts generated by the lysozyme/osmotic shock method--a scaleable way to release periplasmic protein--showed similar robustness between strains. A scale-down mimic of continuous disk-stack centrifugation predicted clarifications in excess of 90% for both intact cells and spheroplasts. Cells over-expressing the Tat pathway performed comparably to cells with the wild-type system. Overall, engineering E. coli cells to over-express the Tat pathway allowed for greater periplasmic yields of FhuD at the fermentation scale without compromising downstream processing performance.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22125050     DOI: 10.1002/bit.24384

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  5 in total

1.  Evaluating a New High-throughput Twin-Arginine Translocase Assay in Bacteria for Therapeutic Applications.

Authors:  Deepanjan Ghosh; Shridhar Chougule; Vellore Sunder Avinash; Sureshkumar Ramasamy
Journal:  Curr Microbiol       Date:  2017-08-04       Impact factor: 2.188

2.  Efficient soluble expression of disulfide bonded proteins in the cytoplasm of Escherichia coli in fed-batch fermentations on chemically defined minimal media.

Authors:  Anna Gąciarz; Narendar Kumar Khatri; M Lourdes Velez-Suberbie; Mirva J Saaranen; Yuko Uchida; Eli Keshavarz-Moore; Lloyd W Ruddock
Journal:  Microb Cell Fact       Date:  2017-06-15       Impact factor: 5.328

3.  High throughput automated microbial bioreactor system used for clone selection and rapid scale-down process optimization.

Authors:  M Lourdes Velez-Suberbie; John P J Betts; Kelly L Walker; Colin Robinson; Barney Zoro; Eli Keshavarz-Moore
Journal:  Biotechnol Prog       Date:  2017-08-10

4.  Engineering the Salt-Inducible Ectoine Promoter Region of Halomonas elongata for Protein Expression in a Unique Stabilizing Environment.

Authors:  Lisa M Stiller; Erwin A Galinski; Elisabeth M H J Witt
Journal:  Genes (Basel)       Date:  2018-03-28       Impact factor: 4.096

5.  Escherichia coli "TatExpress" strains super-secrete human growth hormone into the bacterial periplasm by the Tat pathway.

Authors:  Douglas F Browning; Kirsty L Richards; Amber R Peswani; Jo Roobol; Stephen J W Busby; Colin Robinson
Journal:  Biotechnol Bioeng       Date:  2017-10-06       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.